CC-115
CC-115 Basic information
- Product Name:
- CC-115
- Synonyms:
-
- CS-2038
- CC115;CC 115
- CC-115, >95%
- CC-115(free base)
- 1-Ethyl-7-(2-methyl-6-(4h-1,2,4-triazol-3-yl)pyridin-3-yl)-3,4-dihydropyrazino[2,3-b]pyrazin-2(1h)-one
- CC-115
- 1-ethyl-7-(2-methyl-6-(1H-1,2,4-triazol-5-yl)pyridin-3-yl)-3,4-dihydropyrazino[2,3-b]pyrazin-2(1H)-one
- Pyrazino[2,3-b]pyrazin-2(1H)-one, 1-ethyl-3,4-dihydro-7-[2-methyl-6-(1H-1,2,4-triazol-5-yl)-3-pyridinyl]-
- CAS:
- 1228013-15-7
- MF:
- C16H16N8O
- MW:
- 336.35
- Mol File:
- 1228013-15-7.mol
CC-115 Chemical Properties
- Boiling point:
- 587.3±60.0 °C(Predicted)
- Density
- 1.56±0.1 g/cm3(Predicted)
- storage temp.
- Store at -20°C
- solubility
- ≥50 mg/mL in DMSO; insoluble in EtOH; insoluble in H2O
- form
- solid
- pka
- 5.94±0.20(Predicted)
- color
- Pink to red
CC-115 Usage And Synthesis
Uses
CC-115 is a potent and dual DNA-PK and mTOR kinase inhibitor with IC50s of 13 nM and 21 nM, respectively. CC-115 blocks both mTORC1 and mTORC2 signaling.
Biological Activity
cc-115 is a inhibitor of mtor/dna-pk.the mammalian target of rapamycin (mtor) kinase is a key mediator of the phosphoinositide 3-kinase /protein kinase b (akt pathway). the dna-dependent protein kinase (dna-pk) is a critical component of the dna repair machinery governings the response to dna damage, which serves to maintain genome integrity.
in vitro
previous study found that the proliferation induced by cd40(+) interleukin-21 stimulation could be completely blocked by cc-115, and cd40-mediated resistance to fludarabine and venetoclax could also be reverted by cc-115. moreover, bcr-mediated signaling was blocked by cc-115 and in cll samples from patients with acquired resistance to idelalisib treatment [1].
in vivo
preclinical studies showed that cc-115 had good in vivo pk profiles across multiple species with 53%, 76%, and around100% oral bioavailability in mouse, rat, and dog, respectively [2].
target
| Target | Value |
| DNA-PK (Cell-free assay) | 0.013 μM |
| mTOR (Cell-free assay) | 0.021 μM |
| PI3Kα (Cell-free assay) | 0.852 μM |
IC 50
21/ 13 nm for mtor/dna-pk
References
[1] thijssen r,et al. dual tork/dna-pk inhibition blocks critical signaling pathways in chronic lymphocytic leukemia. blood.2016 jul 28;128(4):574-83.
[2] mortensen ds, et al. optimization of a series of triazole containing mammalian target of rapamycin (mtor) kinase inhibitors and the discovery of cc-115. j med chem. 2015 jul 23;58(14):5599-5608.
CC-115Supplier
- Tel
- sales@boylechem.com
- Tel
- 1-631-485-4226; 16314854226
- info@bocsci.com
- Tel
- 0411-62910999 13889544652
- sales@meilune.com
- Tel
- 021-58950125
- info@chemexpress.com
- Tel
- 18149758185 18149758185;
- sales-cpd@caerulumpharma.com